Back to search

Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation

Data up to Jan 2025

Published1997
Citations106
References59

Total Citations Per Year

Abstract

References (59)

International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

1994 • 1,729 citations

Pharmacologic Analysis of Drug Receptor Interaction

1988 • 936 citations

Cloning and expression of cDNA for a human thromboxane A2 receptor

1991 • 680 citations

Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity

1993 • 546 citations

Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.

1993 • 475 citations

Cloning and expression of a cDNA for the human prostanoid FP receptor.

1994 • 386 citations

Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.

1992 • 385 citations

Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

1994 • 384 citations

Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.

1993 • 381 citations

Molecular Cloning and Characterization of the Human Prostanoid DP Receptor

1995 • 332 citations

Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.

1993 • 305 citations

Studies of the characterisation of prostanoid receptors: A proposed classification

1982 • 305 citations

A novel inhibitory prostanoid receptor in piglet saphenous vein

1994 • 273 citations

Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.

1994 • 244 citations

Cloning and expression of a cDNA for the human prostanoid IP receptor.

1994 • 187 citations

Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues

1986 • 167 citations

Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum

1992 • 154 citations

Prostanoid receptors — the development of a working classification

1984 • 150 citations

Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979

1986 • 149 citations

Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2

1993 • 144 citations

Quantifying Proliferation of Cultured Human and Rabbit Airway Smooth Muscle Cells in Response to Serum and Platelet-derived Growth Factor

1992 • 138 citations

Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype

1995 • 137 citations

Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1994 • 136 citations

Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins.

1988 • 132 citations

Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.

1995 • 129 citations

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

1995 • 129 citations

Isoforms of the EP3 Subtype of Human Prostaglandin E2 Receptor Transduce Both Intracellular Calcium and cAMP Signals

1994 • 122 citations

Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP

1989 • 121 citations

Ligand binding to thromboxane receptors on human platelets: correlation with biological activity

1983 • 111 citations

Focus on prostacyclin and its novel mimetics

1996 • 109 citations

6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist

1995 • 108 citations

Prostacyclin analogs suppress the synthesis of tumor necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells

1993 • 102 citations

Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini

1994 • 100 citations

Potent contractile actions of prostanoid EP3‐receptor agonists on human isolated pulmonary artery

1994 • 92 citations

AH6809, a prostaglandin DP‐receptor blocking drug on human platelets

1988 • 90 citations

Investigation of the prostaglandin E (EP‐) receptor subtype mediating relaxation of the rabbit jugular vein

1992 • 87 citations

New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors.

1987 • 85 citations

Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids

1995 • 80 citations

Cloning and Expression of the EP3-Subtype of Human Receptors for Prostaglandin E2

1994 • 75 citations

Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat

1986 • 73 citations

Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukaemia cells

1994 • 65 citations

A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: Coexpression of EP1, EP2, EP3β and EP4

1996 • 57 citations

Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery

1996 • 56 citations

AH13205, A Selective Prostanoid EP2‐receptor Agonist

1993 • 50 citations

Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: Probable involvement of EP3 receptors

1992 • 47 citations

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3‐ and DP‐receptors

1994 • 40 citations

Exclusive expression of the Gs‐linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM‐3 cells and coexpression of subtype 4 and 2 mRNA in U‐937 cells

1996 • 40 citations

Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.

1994 • 32 citations

Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype

1991 • 29 citations

Characterization of prostanoid receptors on rat neutrophils

1994 • 29 citations

Characterization of the prostaglandin E2 sensitive (EP)‐receptor in the rat isolated trachea

1994 • 28 citations

Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.

1995 • 28 citations

Characterization of the prostanoid receptors mediating inhibition of PAF‐induced aggregation of guinea‐pig eosinophils

1997 • 24 citations

An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat

1995 • 24 citations

Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins

1995 • 23 citations

Prostaglandin E2 Receptors on Human Peripheral Blood Monocytes

1985 • 23 citations

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis

1996 • 17 citations

Characterization of prostaglandin E2 receptors expressed on human monocytic leukaemic cell line, U937

1993 • 11 citations

Characterization of Thromboxane Receptors in Human Platelets

1985 • 10 citations

Cited By (0)

Loading...
Characterization of the prostanoid receptor(s) on human blood monocytes at which… (1997) – British Journal of Pharmacology | Metascience Observatory Explorer